kellia chiu

postdoc @UofTFamilyMed | analyzing pharmaceutical + drug + health professional practice policies | pharmacist

[LongwoodsNotes @LongwoodsNotes]

"Diverse knowledge and policy networks need to be fostered to bridge this east–west divide in #substanceuse care policy," write @doc_Sud @kelliachiu et al in "Methadone Prescribing Regulation for #OpioidUse Disorder in Canada."
https://t.co/Df7QMZ865w

[LongwoodsNotes @LongwoodsNotes]

This raises the possibility that restrictive policies around methadone may be important contributors to higher rates of harm in western provinces vs the east, while looser regulation in the east could be relatively protective. @doc_Sud @kelliachiu
https://t.co/Df7QMZ865w

[Dr Abhimanyu Sud @doc_sud]

🚨New paper alert🚨 w @kelliachiu @JosephRFriedman @JulieDupouy

Other countries often look to France's apparent success with deregulating buprenorphine for opioid use disorder in the '90s - but applying policy lessons across countries & decades is hard!
https://t.co/BnS4qwumA1

[Dr Abhimanyu Sud @doc_sud]

Excited to advance important research w @kelliachiu @Mina__T @jendlake @Tara_Gomes (+ many others) on pharmacist administered long-acting injectable buprenorphine in 🇨🇦+🇦🇺
#opioids @UofTFamilyMed @HRHospital @CAMHnews @ODPRN_Research @UofTPharmacy @SaskHealth @nshealth

[Bloomberg Nursing @UofTNursing]

#ComingUp Don't miss January's Health Inc Seminar Series feat. @QuinnGrundy, Eric Ng, and @KelliaChiu for a discussion on industry interactions in the context of the interprofessional clinic. Reserve your spot for January 19 | 12 PM - 1 PM https://t.co/Yjt1pYBY5t

[Evidence & Policy @EvidencePolicy]

New from @EvidencePolicy:

'A comparative analysis of the roles and use of #evidence in pharmacy #policy in #Australia'

By @kelliachiu et al.

@policypress @BUP_Journals @zpneal @CarolineJOliver

Read it here ⬇️
https://t.co/ego4NvW1Uz

[Evidence & Policy @EvidencePolicy]

New from @EvidencePolicy:

'A comparative analysis of the roles and use of #evidence in pharmacy #policy in #Australia'

By @kelliachiu et al.

@policypress @BUP_Journals @zpneal @CarolineJOliver

Read it here ⬇️
https://t.co/ego4NvW1Uz

[Zhaoli Dai, PhD @DaiZhaoli]

Undisclosed industry payments rampant in drug-trial papers - read our new paper here @ https://t.co/I5cvh6ttvD ⁦⁦@kelliachiu⁩ ⁦@adamgdunn⁩ ⁦@AcademicChatter⁩ #COI https://t.co/mXuntfcUSg

[The Sydney Morning Herald @smh]

One in four Australian medical researchers fails to declare important conflicts of interest in medical trials, such as payments from big pharma companies, a new study claims | @lucy_carroll @liammannix https://t.co/QXIpnXRPiD

[Sydney Health @syd_health]

📣 #SydneyPharmacySchool will be hosting PhD student and registered pharmacist, @kelliachiu, as part of the School's semester seminar series!

👉 Join us today via zoom, 1pm, as Kellia discusses the development of policies affecting community pharmacy practice in Australia.

[kellia chiu @kelliachiu]

this is a great nuanced explanation

[Sally McDonald @SMcDonaldAPD]

The #preprint of our study on #COVID19 preprints is up on @medrxivpreprint. How meta!

Comparison of preprints and final journal publications from COVID-19 Studies: Discrepancies in results reporting and spin in interpretation https://t.co/UNRDMQYKtf

[The BMJ @bmj_latest]

The findings of this new review indicate an association between financial conflicts of interest and favourable recommendations of drugs and devices in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews
https://t.co/PwmVdwt0jA

[The Conversation - Australia + New Zealand @ConversationEDU]

COVID vaccines will be rolled out in the UK as early as next week.

But Australia will have to wait 3 months. Why? https://t.co/yqC7hPheaY @SydneyUni_Media

[The Conversation - Australia + New Zealand @ConversationEDU]

Barbara Mintzes and her team @Sydney_Uni outline four reasons why there's no place for a private market to run alongside Australia's public rollout of a COVID vaccine. https://t.co/DWHyGYmpLw

[kellia chiu @kelliachiu]

@SMcDonaldAPD gotta love how blatant it is!

[Cochrane @cochranecollab]

JUST PUBLISHED - Digital contact tracing technologies in epidemics https://t.co/7goAhrLzgW A Rapid Cochrane Review from @CochranePH #COVID19

[Charles Perkins Centre @CPC_usyd]

New report on the relationship between consumers and the pharmaceutical industry. Led by #CharlesPerkinsCentre members Prof Lisa Bero, A/Prof Barbara Mintzse, Dr @ali_fabbri, @kelliachiu, Jeff Wang & the team @CHFofAustralia @HCNSW. Read the report 👉 https://t.co/HzjWMATljj

[CPC EMCR @CPC_EMCR]

Interested in becoming a member of the CPC EMCR committee? We'd love to hear from you! Apply here https://t.co/V5YzWFN6V6

[The BMJ @bmj_latest]

Conflict of interest disclosures should help us to evaluate risk of bias in biomedical research, but currently they only muddy the waters. We need consensus around the definition of conflict of interest and harmonisation of practices say @QuinnGrundy et al https://t.co/Fp9mnmlAzx